AUG 10, 2022 11:12 AM PDT

Blood Vessel Disease May Worsen Cognition in Alzheimer's Disease

WRITTEN BY: Zoe Michaud

A new study from a group of Alzheimer’s disease researchers at Augusta University is highlighting the importance of vascular disease in Alzheimer’s disease-associated cognitive decline. The research investigated the impact of microscopic blood vessels on the health of white matter in the brain, the ability of diseased blood vessels to dilate, and the resulting impact on cognition as it relates to Alzheimer’s disease. 

The scientists used data from a longitudinal study called the Adult Changes in Thought Study (or ACT). This study is a joint initiative between the Kaiser Permanente Washington Research Institute and the University of Washington which examines the cognitive health of volunteers in Washington over the age of sixty-five. 

The scientists looked at twenty-eight study participants with varying clinical presentations of vascular disease and Alzheimer’s disease. They used a technique called video microscopy to analyze material from the patients’ brains that was donated post mortem. 

The researchers’ main finding was that in individuals diagnosed with Alzheimer’s disease and vascular disease, there was a higher likelihood that the microscopic blood vessels had an impaired ability to dilate in response to a blood vessel dilator. The impaired ability of blood vessels to dilate was associated with white matter injury on an MRI. 

Dr. Zsolt Bagi, a researchers at Augusta University, says that “the main message of this paper is the mixed pathology as we call it — microvascular disease and Alzheimer’s — is associated with more brain damage, more white matter damage and more inflammation,”

Risk factors for developing vascular disease include diabetes, obesity, and high blood pressure. The researchers note that exercise and controlling levels of blood sugar and blood pressure may be effective in preventing the development of vascular disease that impacts Alzheimer’s disease. 

Understanding the complex interactions of various pathologies on Alzheimer’s disease is instrumental in helping researchers identify tactics to improve cognition or prevent Alzheimer’s disease. “You have some genetic predisposition but people realize that not everybody develops memory decline or cognitive deficits unless something else is coming in,” Bagi says. 

Sources: GeroScience, Mayo Clinic

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
SEP 11, 2022
Neuroscience
A Kind of 'Second Synapse' on Neurons - The Cilium
SEP 11, 2022
A Kind of 'Second Synapse' on Neurons - The Cilium
Nearly every type of cell in the human body carries a little antenna-like structure called a cilium, which can serve var ...
SEP 14, 2022
Health & Medicine
Researchers Suggest Updating Alcohol Warning Labels
SEP 14, 2022
Researchers Suggest Updating Alcohol Warning Labels
Current warning labels that appear on alcohol products in the US are outdated, vague, and not helpful to people who want ...
SEP 19, 2022
Genetics & Genomics
Some Gene Variants May Encourage Active or Sedentary Lifestyles
SEP 19, 2022
Some Gene Variants May Encourage Active or Sedentary Lifestyles
There is still a lot of debate about how much a person's genes influence their behavior. Twin studies are one way to hel ...
SEP 23, 2022
Neuroscience
'The Life of her Mind' Episode 1: Dr. Alice Dreger
SEP 23, 2022
'The Life of her Mind' Episode 1: Dr. Alice Dreger
The Life of Her Mind is a new video series focusing on the lives, perspectives, career pathways, and research of women w ...
SEP 16, 2022
Drug Discovery & Development
A magic cure for alcohol use disorder: FDA approves synthetic psilocybin as an investigational new drug for alcohol use disorder.
SEP 16, 2022
A magic cure for alcohol use disorder: FDA approves synthetic psilocybin as an investigational new drug for alcohol use disorder.
Are mushrooms the magic therapeutic to help overcome alcohol use disorder? New data published last month suggest that th ...
SEP 28, 2022
Genetics & Genomics
Microprotein Mutations May Significantly Increase Alzheimer's Risk
SEP 28, 2022
Microprotein Mutations May Significantly Increase Alzheimer's Risk
The mitochondrion, commonly called the powerhouse of the cell, might be one of the best known organelles. This special o ...
Loading Comments...